BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schurgers LJ, Barreto DV, Barreto FC, Liabeuf S, Renard C, Magdeleyns EJ, Vermeer C, Choukroun G, Massy ZA. The circulating inactive form of matrix gla protein is a surrogate marker for vascular calcification in chronic kidney disease: a preliminary report. Clin J Am Soc Nephrol. 2010;5:568-575. [PMID: 20133489 DOI: 10.2215/cjn.07081009] [Cited by in Crossref: 180] [Cited by in F6Publishing: 83] [Article Influence: 15.0] [Reference Citation Analysis]
Number Citing Articles
1 van Ballegooijen AJ, Beulens JW. The Role of Vitamin K Status in Cardiovascular Health: Evidence from Observational and Clinical Studies. Curr Nutr Rep. 2017;6:197-205. [PMID: 28944098 DOI: 10.1007/s13668-017-0208-8] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 7.6] [Reference Citation Analysis]
2 Cozzolino M, Cianciolo G, Podestà MA, Ciceri P, Galassi A, Gasperoni L, Manna G. Current Therapy in CKD Patients Can Affect Vitamin K Status. Nutrients 2020;12:E1609. [PMID: 32486167 DOI: 10.3390/nu12061609] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Viegas CS, Herfs M, Rafael MS, Enriquez JL, Teixeira A, Luís IM, van 't Hoofd CM, João A, Maria VL, Cavaco S, Ferreira A, Serra M, Theuwissen E, Vermeer C, Simes DC. Gla-rich protein is a potential new vitamin K target in cancer: evidences for a direct GRP-mineral interaction. Biomed Res Int 2014;2014:340216. [PMID: 24949434 DOI: 10.1155/2014/340216] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
4 Theuwissen E, Smit E, Vermeer C. The role of vitamin K in soft-tissue calcification. Adv Nutr 2012;3:166-73. [PMID: 22516724 DOI: 10.3945/an.111.001628] [Cited by in Crossref: 72] [Cited by in F6Publishing: 63] [Article Influence: 7.2] [Reference Citation Analysis]
5 Fusaro M, Cianciolo G, Evenepoel P, Schurgers L, Plebani M. Vitamin K in CKD Bone Disorders. Calcif Tissue Int 2021;108:476-85. [PMID: 33409597 DOI: 10.1007/s00223-020-00792-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
6 Jia F, Wang S, Jing Y, Zhao H, Rong P, Zhang H, Lu W, Xue Y, Sun G. Osteocalcin and Abdominal Aortic Calcification in Hemodialysis Patients: An Observational Cross-Sectional Study. Front Endocrinol (Lausanne) 2021;12:620350. [PMID: 33815281 DOI: 10.3389/fendo.2021.620350] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Shea MK, Holden RM. Vitamin K status and vascular calcification: evidence from observational and clinical studies. Adv Nutr. 2012;3:158-165. [PMID: 22516723 DOI: 10.3945/an.111.001644] [Cited by in Crossref: 77] [Cited by in F6Publishing: 65] [Article Influence: 7.7] [Reference Citation Analysis]
8 Wasilewski GB, Vervloet MG, Schurgers LJ. The Bone-Vasculature Axis: Calcium Supplementation and the Role of Vitamin K. Front Cardiovasc Med 2019;6:6. [PMID: 30805347 DOI: 10.3389/fcvm.2019.00006] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
9 Delanaye P, Krzesinski JM, Warling X, Moonen M, Smelten N, Médart L, Pottel H, Cavalier E. Dephosphorylated-uncarboxylated Matrix Gla protein concentration is predictive of vitamin K status and is correlated with vascular calcification in a cohort of hemodialysis patients. BMC Nephrol. 2014;15:145. [PMID: 25190488 DOI: 10.1186/1471-2369-15-145] [Cited by in Crossref: 65] [Cited by in F6Publishing: 62] [Article Influence: 8.1] [Reference Citation Analysis]
10 Shioi A, Morioka T, Shoji T, Emoto M. The Inhibitory Roles of Vitamin K in Progression of Vascular Calcification. Nutrients 2020;12:E583. [PMID: 32102248 DOI: 10.3390/nu12020583] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
11 Bartstra JW, Draaisma F, Zwakenberg SR, Lessmann N, Wolterink JM, van der Schouw YT, de Jong PA, Beulens JWJ. Six months vitamin K treatment does not affect systemic arterial calcification or bone mineral density in diabetes mellitus 2. Eur J Nutr 2021;60:1691-9. [PMID: 33068157 DOI: 10.1007/s00394-020-02412-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
12 Boxma PY, van den Berg E, Geleijnse JM, Laverman GD, Schurgers LJ, Vermeer C, Kema IP, Muskiet FA, Navis G, Bakker SJ, de Borst MH. Vitamin k intake and plasma desphospho-uncarboxylated matrix Gla-protein levels in kidney transplant recipients. PLoS One 2012;7:e47991. [PMID: 23118917 DOI: 10.1371/journal.pone.0047991] [Cited by in Crossref: 57] [Cited by in F6Publishing: 52] [Article Influence: 5.7] [Reference Citation Analysis]
13 Caluwé R, Pyfferoen L, De Boeck K, De Vriese AS. The effects of vitamin K supplementation and vitamin K antagonists on progression of vascular calcification: ongoing randomized controlled trials. Clin Kidney J 2016;9:273-9. [PMID: 26985380 DOI: 10.1093/ckj/sfv146] [Cited by in Crossref: 58] [Cited by in F6Publishing: 47] [Article Influence: 8.3] [Reference Citation Analysis]
14 Louvet L, Büchel J, Steppan S, Passlick-Deetjen J, Massy ZA. Magnesium prevents phosphate-induced calcification in human aortic vascular smooth muscle cells. Nephrol Dial Transplant. 2013;28:869-878. [PMID: 23229924 DOI: 10.1093/ndt/gfs520] [Cited by in Crossref: 109] [Cited by in F6Publishing: 108] [Article Influence: 10.9] [Reference Citation Analysis]
15 Hashimoto Y, Mori M, Kobayashi S, Hanya A, Watanabe SI, Ohara N, Noguchi T, Kawai T, Okuyama H. Canola and hydrogenated soybean oils accelerate ectopic bone formation induced by implantation of bone morphogenetic protein in mice. Toxicol Rep 2014;1:955-62. [PMID: 28962307 DOI: 10.1016/j.toxrep.2014.10.021] [Cited by in Crossref: 4] [Article Influence: 0.5] [Reference Citation Analysis]
16 Ho HJ, Komai M, Shirakawa H. Beneficial Effects of Vitamin K Status on Glycemic Regulation and Diabetes Mellitus: A Mini-Review. Nutrients 2020;12:E2485. [PMID: 32824773 DOI: 10.3390/nu12082485] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Dalmeijer GW, van der Schouw YT, Magdeleyns EJ, Vermeer C, Verschuren WM, Boer JM, Beulens JW. Matrix Gla protein species and risk of cardiovascular events in type 2 diabetic patients. Diabetes Care 2013;36:3766-71. [PMID: 23877986 DOI: 10.2337/dc13-0065] [Cited by in Crossref: 68] [Cited by in F6Publishing: 65] [Article Influence: 7.6] [Reference Citation Analysis]
18 Wei FF, Trenson S, Verhamme P, Vermeer C, Staessen JA. Vitamin K-Dependent Matrix Gla Protein as Multifaceted Protector of Vascular and Tissue Integrity. Hypertension 2019;73:1160-9. [PMID: 31006332 DOI: 10.1161/HYPERTENSIONAHA.119.12412] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
19 Gluba-Brzózka A, Michalska-Kasiczak M, Franczyk B, Nocuń M, Toth P, Banach M, Rysz J. Markers of increased atherosclerotic risk in patients with chronic kidney disease: a preliminary study. Lipids Health Dis 2016;15:22. [PMID: 26843213 DOI: 10.1186/s12944-016-0191-x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
20 Rapp N, Brandenburg VM, Kaesler N, Bakker SJL, Stöhr R, Schuh A, Evenepoel P, Schurgers LJ. Hepatic and Vascular Vitamin K Status in Patients with High Cardiovascular Risk. Nutrients 2021;13:3490. [PMID: 34684491 DOI: 10.3390/nu13103490] [Reference Citation Analysis]
21 Silaghi CN, Ilyés T, Filip VP, Farcaș M, van Ballegooijen AJ, Crăciun AM. Vitamin K Dependent Proteins in Kidney Disease. Int J Mol Sci 2019;20:E1571. [PMID: 30934817 DOI: 10.3390/ijms20071571] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
22 Viegas C, Araújo N, Marreiros C, Simes D. The interplay between mineral metabolism, vascular calcification and inflammation in Chronic Kidney Disease (CKD): challenging old concepts with new facts. Aging (Albany NY) 2019;11:4274-99. [PMID: 31241466 DOI: 10.18632/aging.102046] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 13.0] [Reference Citation Analysis]
23 Roumeliotis S, Dounousi E, Salmas M, Eleftheriadis T, Liakopoulos V. Vascular Calcification in Chronic Kidney Disease: The Role of Vitamin K- Dependent Matrix Gla Protein. Front Med (Lausanne) 2020;7:154. [PMID: 32391368 DOI: 10.3389/fmed.2020.00154] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
24 Aoun M, Makki M, Azar H, Matta H, Chelala DN. High Dephosphorylated-Uncarboxylated MGP in Hemodialysis patients: risk factors and response to vitamin K2, A pre-post intervention clinical trial. BMC Nephrol 2017;18:191. [PMID: 28592319 DOI: 10.1186/s12882-017-0609-3] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 7.0] [Reference Citation Analysis]
25 Vlasschaert C, Goss CJ, Pilkey NG, McKeown S, Holden RM. Vitamin K Supplementation for the Prevention of Cardiovascular Disease: Where Is the Evidence? A Systematic Review of Controlled Trials. Nutrients 2020;12:E2909. [PMID: 32977548 DOI: 10.3390/nu12102909] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
26 Jansz TT, Neradova A, van Ballegooijen AJ, Verhaar MC, Vervloet MG, Schurgers LJ, van Jaarsveld BC. The role of kidney transplantation and phosphate binder use in vitamin K status. PLoS One 2018;13:e0203157. [PMID: 30161193 DOI: 10.1371/journal.pone.0203157] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 5.8] [Reference Citation Analysis]
27 Scheiber D, Veulemans V, Horn P, Chatrou ML, Potthoff SA, Kelm M, Schurgers LJ, Westenfeld R. High-Dose Menaquinone-7 Supplementation Reduces Cardiovascular Calcification in a Murine Model of Extraosseous Calcification. Nutrients 2015;7:6991-7011. [PMID: 26295257 DOI: 10.3390/nu7085318] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 4.6] [Reference Citation Analysis]
28 Elliott MJ, Booth SL, Hopman WM, Holden RM. Assessment of potential biomarkers of subclinical vitamin K deficiency in patients with end-stage kidney disease. Can J Kidney Health Dis 2014;1:13. [PMID: 25780608 DOI: 10.1186/2054-3581-1-13] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
29 Turck D, Bresson JL, Burlingame B, Dean T, Fairweather-Tait S, Heinonen M, Hirsch-Ernst KI, Mangelsdorf I, McArdle HJ, Naska A, Nowicka G, Pentieva K, Sanz Y, Siani A, Sjödin A, Stern M, Tomé D, Van Loveren H, Vinceti M, Willatts P, Lamberg-Allardt C, Przyrembel H, Tetens I, Dumas C, Fabiani L, Ioannidou S, Neuhäuser-Berthold M; EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA). Dietary reference values for vitamin K. EFSA J 2017;15:e04780. [PMID: 32625486 DOI: 10.2903/j.efsa.2017.4780] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
30 Roumeliotis S, Dounousi E, Eleftheriadis T, Liakopoulos V. Association of the Inactive Circulating Matrix Gla Protein with Vitamin K Intake, Calcification, Mortality, and Cardiovascular Disease: A Review. Int J Mol Sci 2019;20:E628. [PMID: 30717170 DOI: 10.3390/ijms20030628] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 11.0] [Reference Citation Analysis]
31 Lee SJ, Lee IK, Jeon JH. Vascular Calcification-New Insights Into Its Mechanism. Int J Mol Sci 2020;21:E2685. [PMID: 32294899 DOI: 10.3390/ijms21082685] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 21.0] [Reference Citation Analysis]
32 Paloian NJ, Giachelli CM. A current understanding of vascular calcification in CKD. Am J Physiol Renal Physiol 2014;307:F891-900. [PMID: 25143458 DOI: 10.1152/ajprenal.00163.2014] [Cited by in Crossref: 172] [Cited by in F6Publishing: 160] [Article Influence: 21.5] [Reference Citation Analysis]
33 Schlieper G, Westenfeld R, Krüger T, Cranenburg EC, Magdeleyns EJ, Brandenburg VM, Djuric Z, Damjanovic T, Ketteler M, Vermeer C, Dimkovic N, Floege J, Schurgers LJ. Circulating nonphosphorylated carboxylated matrix gla protein predicts survival in ESRD. J Am Soc Nephrol 2011;22:387-95. [PMID: 21289218 DOI: 10.1681/ASN.2010040339] [Cited by in Crossref: 159] [Cited by in F6Publishing: 69] [Article Influence: 14.5] [Reference Citation Analysis]
34 Farese S, Stauffer E, Kalicki R, Hildebrandt T, Frey BM, Frey FJ, Uehlinger DE, Pasch A. Sodium thiosulfate pharmacokinetics in hemodialysis patients and healthy volunteers. Clin J Am Soc Nephrol. 2011;6:1447-1455. [PMID: 21566113 DOI: 10.2215/cjn.10241110] [Cited by in Crossref: 31] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
35 Evenepoel P, Dejongh S, Verbeke K, Meijers B. The Role of Gut Dysbiosis in the Bone-Vascular Axis in Chronic Kidney Disease. Toxins (Basel) 2020;12:E285. [PMID: 32365480 DOI: 10.3390/toxins12050285] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
36 Chirinos JA, Sardana M, Syed AA, Koppula MR, Varakantam S, Vasim I, Oldland HG, Phan TS, Drummen NEA, Vermeer C, Townsend RR, Akers SR, Wei W, Lakatta EG, Fedorova OV. Aldosterone, inactive matrix gla-protein, and large artery stiffness in hypertension. J Am Soc Hypertens 2018;12:681-9. [PMID: 30033123 DOI: 10.1016/j.jash.2018.06.018] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
37 Shea MK, Berkner KL, Ferland G, Fu X, Holden RM, Booth SL. Perspective: Evidence before Enthusiasm-A Critical Review of the Potential Cardiovascular Benefits of Vitamin K. Adv Nutr 2021;12:632-46. [PMID: 33684212 DOI: 10.1093/advances/nmab004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Vermeer C. Vitamin K: the effect on health beyond coagulation - an overview. Food Nutr Res. 2012;56. [PMID: 22489224 DOI: 10.3402/fnr.v56i0.5329] [Cited by in Crossref: 81] [Cited by in F6Publishing: 62] [Article Influence: 8.1] [Reference Citation Analysis]
39 Cancela ML, Laizé V, Conceição N, Kempf H, Murshed M. Keutel Syndrome, a Review of 50 Years of Literature. Front Cell Dev Biol 2021;9:642136. [PMID: 33996798 DOI: 10.3389/fcell.2021.642136] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
40 Levy-Schousboe K, Frimodt-Møller M, Hansen D, Peters CD, Kjærgaard KD, Jensen JD, Strandhave C, Elming H, Larsen CT, Sandstrøm H, Brasen CL, Schmedes A, Madsen JS, Jørgensen NR, Frøkjær JB, Frandsen NE, Petersen I, Marckmann P. Vitamin K supplementation and arterial calcification in dialysis: results of the double-blind, randomized, placebo-controlled RenaKvit trial. Clin Kidney J 2021;14:2114-23. [PMID: 34476095 DOI: 10.1093/ckj/sfab017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
41 Thent ZC, Froemming GRA, Muid SA. Does Vitamin K Intake Influence High Phosphate Induced Vascular Pseudo-ossification: An Underappreciated Therapeutic Prospect in General Population? Curr Drug Targets 2019;20:421-30. [PMID: 30378497 DOI: 10.2174/1389450119666181031124430] [Reference Citation Analysis]
42 Dai L, Li L, Erlandsson H, Jaminon AMG, Qureshi AR, Ripsweden J, Brismar TB, Witasp A, Heimbürger O, Jørgensen HS, Barany P, Lindholm B, Evenepoel P, Schurgers LJ, Stenvinkel P. Functional vitamin K insufficiency, vascular calcification and mortality in advanced chronic kidney disease: A cohort study. PLoS One 2021;16:e0247623. [PMID: 33626087 DOI: 10.1371/journal.pone.0247623] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Kremer D, Groothof D, Keyzer CA, Eelderink C, Knobbe TJ, Post A, van Londen M, Eisenga MF, TransplantLines Investigators, Schurgers LJ, Berger SP, de Borst MH, Bakker SJL. Kidney Function-Dependence of Vitamin K-Status Parameters: Results from the TransplantLines Biobank and Cohort Studies. Nutrients 2021;13:3069. [PMID: 34578950 DOI: 10.3390/nu13093069] [Reference Citation Analysis]
44 Dai L, Meijers BK, Bammens B, de Loor H, Schurgers LJ, Qureshi AR, Stenvinkel P, Evenepoel P. Sevelamer Use in End-Stage Kidney Disease (ESKD) Patients Associates with Poor Vitamin K Status and High Levels of Gut-Derived Uremic Toxins: A Drug-Bug Interaction? Toxins (Basel) 2020;12:E351. [PMID: 32471179 DOI: 10.3390/toxins12060351] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
45 Tsang HG, Clark EL, Markby GR, Bush SJ, Hume DA, Corcoran BM, MacRae VE, Summers KM. Expression of Calcification and Extracellular Matrix Genes in the Cardiovascular System of the Healthy Domestic Sheep (Ovis aries). Front Genet 2020;11:919. [PMID: 33101359 DOI: 10.3389/fgene.2020.00919] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
46 Neradova A, Schumacher SP, Hubeek I, Lux P, Schurgers LJ, Vervloet MG. Phosphate binders affect vitamin K concentration by undesired binding, an in vitro study. BMC Nephrol 2017;18:149. [PMID: 28464802 DOI: 10.1186/s12882-017-0560-3] [Cited by in Crossref: 35] [Cited by in F6Publishing: 25] [Article Influence: 7.0] [Reference Citation Analysis]
47 Cozzolino M, Mangano M, Galassi A, Ciceri P, Messa P, Nigwekar S. Vitamin K in Chronic Kidney Disease. Nutrients 2019;11:E168. [PMID: 30646590 DOI: 10.3390/nu11010168] [Cited by in Crossref: 30] [Cited by in F6Publishing: 17] [Article Influence: 10.0] [Reference Citation Analysis]
48 Barrett H, O'Keeffe M, Kavanagh E, Walsh M, O'Connor EM. Is Matrix Gla Protein Associated with Vascular Calcification? A Systematic Review. Nutrients. 2018;10. [PMID: 29584693 DOI: 10.3390/nu10040415] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 9.3] [Reference Citation Analysis]
49 Fitzpatrick J, Kim ED, Sozio SM, Jaar BG, Estrella MM, Monroy-Trujillo JM, Parekh RS. Calcification Biomarkers, Subclinical Vascular Disease, and Mortality Among Multiethnic Dialysis Patients. Kidney Int Rep 2020;5:1729-37. [PMID: 33102965 DOI: 10.1016/j.ekir.2020.07.033] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
50 Wen L, Chen J, Duan L, Li S. Vitamin K‑dependent proteins involved in bone and cardiovascular health (Review). Mol Med Rep 2018;18:3-15. [PMID: 29749440 DOI: 10.3892/mmr.2018.8940] [Cited by in Crossref: 17] [Cited by in F6Publishing: 24] [Article Influence: 4.3] [Reference Citation Analysis]
51 Danziger J, Young RL, Shea MK, Tracy RP, Ix JH, Jenny NS, Mukamal KJ. Vitamin K-Dependent Protein Activity and Incident Ischemic Cardiovascular Disease: The Multi-Ethnic Study of Atherosclerosis. Arterioscler Thromb Vasc Biol 2016;36:1037-42. [PMID: 27034472 DOI: 10.1161/ATVBAHA.116.307273] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
52 Mayer O Jr, Seidlerová J, Wohlfahrt P, Filipovský J, Vaněk J, Cífková R, Windrichová J, Topolčan O, Knapen MH, Drummen NE, Vermeer C. Desphospho-uncarboxylated matrix Gla protein is associated with increased aortic stiffness in a general population. J Hum Hypertens 2016;30:418-23. [PMID: 26016598 DOI: 10.1038/jhh.2015.55] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 5.4] [Reference Citation Analysis]
53 Răduț R, Crăciun AM, Silaghi CN. BONE MARKERS IN ARTHROPATHIES. Acta Clin Croat 2019;58:716-25. [PMID: 32595257 DOI: 10.20471/acc.2019.58.04.19] [Reference Citation Analysis]
54 Bilalic A, Ticinovic Kurir T, Kumric M, Borovac JA, Matetic A, Supe-Domic D, Bozic J. Circulating Levels of Dephosphorylated-Uncarboxylated Matrix Gla Protein in Patients with Acute Coronary Syndrome. Molecules 2021;26:1108. [PMID: 33669806 DOI: 10.3390/molecules26041108] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
55 Turner ME, Adams MA, Holden RM. The Vitamin K Metabolome in Chronic Kidney Disease. Nutrients 2018;10:E1076. [PMID: 30103541 DOI: 10.3390/nu10081076] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
56 Lupo MG, Biancorosso N, Brilli E, Tarantino G, Adorni MP, Vivian G, Salvalaio M, Dall'Acqua S, Sut S, Neutel C, Chen H, Bressan A, Faggin E, Rattazzi M, Ferri N. Cholesterol-Lowering Action of a Novel Nutraceutical Combination in Uremic Rats: Insights into the Molecular Mechanism in a Hepatoma Cell Line. Nutrients 2020;12:E436. [PMID: 32050453 DOI: 10.3390/nu12020436] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
57 DiNicolantonio JJ, Bhutani J, O'Keefe JH. The health benefits of vitamin K. Open Heart 2015;2:e000300. [PMID: 26468402 DOI: 10.1136/openhrt-2015-000300] [Cited by in Crossref: 38] [Cited by in F6Publishing: 27] [Article Influence: 5.4] [Reference Citation Analysis]
58 Chen W, Fitzpatrick J, Monroy-Trujillo JM, Sozio SM, Jaar BG, Estrella MM, Serrano J, Anokhina V, Miller BL, Melamed ML, Bushinsky DA, Parekh RS. Associations of Serum Calciprotein Particle Size and Transformation Time With Arterial Calcification, Arterial Stiffness, and Mortality in Incident Hemodialysis Patients. Am J Kidney Dis 2021;77:346-54. [PMID: 32800846 DOI: 10.1053/j.ajkd.2020.05.031] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
59 Riphagen IJ, Keyzer CA, Drummen NEA, de Borst MH, Beulens JWJ, Gansevoort RT, Geleijnse JM, Muskiet FAJ, Navis G, Visser ST, Vermeer C, Kema IP, Bakker SJL. Prevalence and Effects of Functional Vitamin K Insufficiency: The PREVEND Study. Nutrients 2017;9:E1334. [PMID: 29292751 DOI: 10.3390/nu9121334] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 5.0] [Reference Citation Analysis]
60 Wei FF, Drummen NE, Thijs L, Jacobs L, Herfs M, Van't Hoofd C, Vermeer C, Staessen JA. Vitamin-K-Dependent Protection of the Renal Microvasculature: Histopathological Studies in Normal and Diseased Kidneys. Pulse (Basel) 2016;4:85-91. [PMID: 27752480 DOI: 10.1159/000448008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
61 Popa DS, Bigman G, Rusu ME. The Role of Vitamin K in Humans: Implication in Aging and Age-Associated Diseases. Antioxidants (Basel) 2021;10:566. [PMID: 33917442 DOI: 10.3390/antiox10040566] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
62 Miyata KN, Nast CC, Dai T, Dukkipati R, LaPage JA, Troost JP, Schurgers LJ, Kretzler M, Adler SG. Renal matrix Gla protein expression increases progressively with CKD and predicts renal outcome. Exp Mol Pathol 2018;105:120-9. [PMID: 29981754 DOI: 10.1016/j.yexmp.2018.07.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
63 Mazur P, Kopytek M, Ząbczyk M, Undas A, Natorska J. Towards Personalized Therapy of Aortic Stenosis. J Pers Med 2021;11:1292. [PMID: 34945764 DOI: 10.3390/jpm11121292] [Reference Citation Analysis]
64 Roumeliotis S, Roumeliotis A, Stamou A, Leivaditis K, Kantartzi K, Panagoutsos S, Liakopoulos V. The Association of dp-ucMGP with Cardiovascular Morbidity and Decreased Renal Function in Diabetic Chronic Kidney Disease. Int J Mol Sci 2020;21:E6035. [PMID: 32839405 DOI: 10.3390/ijms21176035] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
65 Drüeke TB. Calcimimetics and outcomes in CKD. Kidney Int Suppl (2011) 2013;3:431-5. [PMID: 25028644 DOI: 10.1038/kisup.2013.90] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
66 Epstein M. Matrix Gla-Protein (MGP) Not Only Inhibits Calcification in Large Arteries But Also May Be Renoprotective: Connecting the Dots. EBioMedicine. 2016;4:16-17. [PMID: 26981564 DOI: 10.1016/j.ebiom.2016.01.026] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
67 Ponziani FR, Pompili M, Di Stasio E, Zocco MA, Gasbarrini A, Flore R. Subclinical atherosclerosis is linked to small intestinal bacterial overgrowth via vitamin K2-dependent mechanisms. World J Gastroenterol 2017; 23(7): 1241-1249 [PMID: 28275304 DOI: 10.3748/wjg.v23.i7.1241] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
68 Kumric M, Borovac JA, Ticinovic Kurir T, Martinovic D, Frka Separovic I, Baric L, Bozic J. Role of Matrix Gla Protein in the Complex Network of Coronary Artery Disease: A Comprehensive Review. Life (Basel) 2021;11:737. [PMID: 34440481 DOI: 10.3390/life11080737] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
69 Lampropoulos CE, Papaioannou I, D’Cruz DP. Osteoporosis-a risk factor for cardiovascular disease? Nat Rev Rheumatol. 2012;8:587-598. [PMID: 22890244 DOI: 10.1038/nrrheum.2012.120] [Cited by in Crossref: 102] [Cited by in F6Publishing: 92] [Article Influence: 10.2] [Reference Citation Analysis]
70 Griffin TP, Islam MN, Wall D, Ferguson J, Griffin DG, Griffin MD, O'Shea PM. Plasma dephosphorylated-uncarboxylated Matrix Gla-Protein (dp-ucMGP): reference intervals in Caucasian adults and diabetic kidney disease biomarker potential. Sci Rep 2019;9:18452. [PMID: 31804541 DOI: 10.1038/s41598-019-54762-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
71 O'Keefe JH, Bergman N, Carrera-Bastos P, Fontes-Villalba M, DiNicolantonio JJ, Cordain L. Nutritional strategies for skeletal and cardiovascular health: hard bones, soft arteries, rather than vice versa. Open Heart 2016;3:e000325. [PMID: 27042317 DOI: 10.1136/openhrt-2015-000325] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
72 Disthabanchong S. Vascular calcification in chronic kidney disease: Pathogenesis and clinical implication. World J Nephrol 2012; 1(2): 43-53 [PMID: 24175241 DOI: 10.5527/wjn.v1.i2.43] [Cited by in CrossRef: 38] [Cited by in F6Publishing: 37] [Article Influence: 3.8] [Reference Citation Analysis]
73 Ketteler M, Schanz M, Schricker S. Vitamin K: should we supplement to protect the kidneys and the heart? Nephrol Dial Transplant 2021;36:2196-8. [PMID: 31943083 DOI: 10.1093/ndt/gfz291] [Reference Citation Analysis]
74 Péter S, Navis G, de Borst MH, von Schacky C, van Orten-Luiten ACB, Zhernakova A, Witkamp RF, Janse A, Weber P, Bakker SJL, Eggersdorfer M. Public health relevance of drug-nutrition interactions. Eur J Nutr 2017;56:23-36. [PMID: 28748481 DOI: 10.1007/s00394-017-1510-3] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]
75 McCabe KM, Adams MA, Holden RM. Vitamin K status in chronic kidney disease. Nutrients 2013;5:4390-8. [PMID: 24212088 DOI: 10.3390/nu5114390] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
76 Aronson D, Kapeliovich M, Hammerman H, Dragu R. The relation between serum phosphorus levels and clinical outcomes after acute myocardial infarction. PLoS One 2013;8:e58348. [PMID: 23505492 DOI: 10.1371/journal.pone.0058348] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
77 Lau WL, Huisa BN, Fisher M. The Cerebrovascular-Chronic Kidney Disease Connection: Perspectives and Mechanisms. Transl Stroke Res 2017;8:67-76. [PMID: 27628245 DOI: 10.1007/s12975-016-0499-x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 37] [Article Influence: 7.5] [Reference Citation Analysis]
78 Liabeuf S, Bourron O, Vemeer C, Theuwissen E, Magdeleyns E, Aubert CE, Brazier M, Mentaverri R, Hartemann A, Massy ZA. Vascular calcification in patients with type 2 diabetes: the involvement of matrix Gla protein. Cardiovasc Diabetol. 2014;13:85. [PMID: 24762216 DOI: 10.1186/1475-2840-13-85] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 6.1] [Reference Citation Analysis]
79 Zununi Vahed S, Mostafavi S, Hosseiniyan Khatibi SM, Shoja MM, Ardalan M. Vascular Calcification: An Important Understanding in Nephrology. Vasc Health Risk Manag 2020;16:167-80. [PMID: 32494148 DOI: 10.2147/VHRM.S242685] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
80 Ferrer MD, Pérez MM, Cànaves MM, Buades JM, Salcedo C, Perelló J. A novel pharmacodynamic assay to evaluate the effects of crystallization inhibitors on calcium phosphate crystallization in human plasma. Sci Rep 2017;7:6858. [PMID: 28761091 DOI: 10.1038/s41598-017-07203-x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 4.4] [Reference Citation Analysis]
81 Puzantian H, Akers SR, Oldland G, Javaid K, Miller R, Ge Y, Ansari B, Lee J, Suri A, Hasmath Z, Townsend R, Chirinos JA. Circulating Dephospho-Uncarboxylated Matrix Gla-Protein Is Associated With Kidney Dysfunction and Arterial Stiffness. Am J Hypertens 2018;31:988-94. [PMID: 29788226 DOI: 10.1093/ajh/hpy079] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 10.3] [Reference Citation Analysis]
82 Nelson AJ, Raggi P, Wolf M, Gold AM, Chertow GM, Roe MT. Targeting Vascular Calcification in Chronic Kidney Disease. JACC Basic Transl Sci 2020;5:398-412. [PMID: 32368697 DOI: 10.1016/j.jacbts.2020.02.002] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 11.5] [Reference Citation Analysis]
83 Karsli-Ceppioglu S, Yazar S, Keskin Y, Karaca M, Luleci NE, Yurdun T. Association of Genetic Polymorphisms in the Matrix Gla Protein (MGP) Gene with Coronary Artery Disease and Serum MGP Levels. Balkan J Med Genet 2019;22:43-50. [PMID: 31942416 DOI: 10.2478/bjmg-2019-0020] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
84 Shea MK, O'Donnell CJ, Vermeer C, Magdeleyns EJ, Crosier MD, Gundberg CM, Ordovas JM, Kritchevsky SB, Booth SL. Circulating uncarboxylated matrix gla protein is associated with vitamin K nutritional status, but not coronary artery calcium, in older adults. J Nutr 2011;141:1529-34. [PMID: 21628633 DOI: 10.3945/jn.111.139634] [Cited by in Crossref: 75] [Cited by in F6Publishing: 75] [Article Influence: 6.8] [Reference Citation Analysis]
85 Vervloet M. Modifying Phosphate Toxicity in Chronic Kidney Disease. Toxins (Basel). 2019;11:522. [PMID: 31505780 DOI: 10.3390/toxins11090522] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
86 Jaques DA, Pivin E, Pruijm M, Ackermann D, Guessous I, Ehret G, Wei FF, Staessen JA, Pechère-Bertschi A, Vermeer C, Vogt B, Burnier M, Martin PY, Bochud M, Ponte B. Renal Resistive Index Is Associated With Inactive Matrix Gla (γ-Carboxyglutamate) Protein in an Adult Population-Based Study. J Am Heart Assoc 2019;8:e013558. [PMID: 31510823 DOI: 10.1161/JAHA.119.013558] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
87 Shea MK, Booth SL. Vitamin K, Vascular Calcification, and Chronic Kidney Disease: Current Evidence and Unanswered Questions. Curr Dev Nutr 2019;3:nzz077. [PMID: 31598579 DOI: 10.1093/cdn/nzz077] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
88 Wei FF, Drummen NE, Schutte AE, Thijs L, Jacobs L, Petit T, Yang WY, Smith W, Zhang ZY, Gu YM, Kuznetsova T, Verhamme P, Allegaert K, Schutte R, Lerut E, Evenepoel P, Vermeer C, Staessen JA. Vitamin K Dependent Protection of Renal Function in Multi-ethnic Population Studies. EBioMedicine 2016;4:162-9. [PMID: 26981580 DOI: 10.1016/j.ebiom.2016.01.011] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 4.8] [Reference Citation Analysis]
89 Bäck M, Aranyi T, Cancela ML, Carracedo M, Conceição N, Leftheriotis G, Macrae V, Martin L, Nitschke Y, Pasch A, Quaglino D, Rutsch F, Shanahan C, Sorribas V, Szeri F, Valdivielso P, Vanakker O, Kempf H. Endogenous Calcification Inhibitors in the Prevention of Vascular Calcification: A Consensus Statement From the COST Action EuroSoftCalcNet. Front Cardiovasc Med 2018;5:196. [PMID: 30713844 DOI: 10.3389/fcvm.2018.00196] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 13.0] [Reference Citation Analysis]
90 Malhotra R, Nicholson CJ, Wang D, Bhambhani V, Paniagua S, Slocum C, Sigurslid HH, Lino Cardenas CL, Li R, Boerboom SL, Chen YC, Hwang SJ, Yao C, Ichinose F, Bloch DB, Lindsay ME, Lewis GD, Aragam JR, Hoffmann U, Mitchell GF, Hamburg NM, Vasan RS, Benjamin EJ, Larson MG, Zapol WM, Cheng S, Roh JD, O'Donnell CJ, Nguyen C, Levy D, Ho JE. Matrix Gla Protein Levels Are Associated With Arterial Stiffness and Incident Heart Failure With Preserved Ejection Fraction. Arterioscler Thromb Vasc Biol 2021;:ATVBAHA121316664. [PMID: 34809448 DOI: 10.1161/ATVBAHA.121.316664] [Reference Citation Analysis]